Add time:07/13/2019         Source:sciencedirect.com

Inspired by that the multi-target inhibitors against receptor tyrosine kinases (RTKs) have significantly improved the effect of clinical treatment for cancer, and based on the chemical structure of Linifanib (ABT-869, Abbott), two series of diaryl-ureas with novel isoxazol[3,4-b]pyridine-3-amino-structure were designed and synthesized as multi-target inhibitors against RTKs. The preliminary biological evaluation showed that several compounds exhibited comparable potency with Linifanib. Compound S21 was identified as the most potent inhibitor against Fms-like tyrosine kinase 3 (FLT-3), kinase insert domain containing receptor (KDR) and platelet-derived growth factor receptor β (PDGFR-β) with its IC50 values were 4 nM, 3 nM and 8 nM respectively, it also showed potent inhibitory activities against several cancer cells.

We also recommend Trading Suppliers and Manufacturers of 3-(4-chlorophenyl)-7-hydroxy-8-(morpholinomethyl)-2-(trifluoromethyl)-4H-chromen-4-one (cas 307507-07-9). Pls Click Website Link as below: cas 307507-07-9 suppliers